Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Jennison Associates LLC

Jennison Associates LLC cut its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 88.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,667 shares of the biotechnology company’s stock after selling 21,315 shares during the period. Jennison Associates LLC’s holdings in Axon Enterprise were worth $689,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. BKM Wealth Management LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at $32,000. Key Financial Inc grew its stake in shares of Axon Enterprise by 367.6% in the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock valued at $41,000 after buying an additional 125 shares in the last quarter. Lindbrook Capital LLC grew its stake in Axon Enterprise by 43.3% during the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after purchasing an additional 52 shares in the last quarter. Rakuten Securities Inc. acquired a new position in Axon Enterprise during the 4th quarter worth $48,000. Finally, Provence Wealth Management Group acquired a new position in Axon Enterprise during the 3rd quarter worth $80,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Trading Up 0.6 %

NASDAQ:AXON opened at $308.23 on Friday. Axon Enterprise, Inc. has a 1 year low of $175.37 and a 1 year high of $329.87. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The stock has a market cap of $23.26 billion, a P/E ratio of 134.01 and a beta of 0.93. The stock has a 50-day simple moving average of $304.22 and a 200-day simple moving average of $261.92.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The business had revenue of $432.14 million during the quarter, compared to the consensus estimate of $418.97 million. As a group, analysts anticipate that Axon Enterprise, Inc. will post 2.44 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently commented on AXON. The Goldman Sachs Group boosted their target price on Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. Morgan Stanley boosted their target price on Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday. JMP Securities boosted their target price on Axon Enterprise from $250.00 to $285.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 6th. Finally, Argus initiated coverage on Axon Enterprise in a research report on Wednesday, March 13th. They set a “buy” rating and a $380.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $314.91.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.